doi: 10.1111/imm.13178 10 OhkuraNSakaguchiS
While precise global estimates regarding the prevalence of ocular conditions remain limited, the World Health Organization has posited that the burden disproportionately weighs heavier on low- and middle-income countries and among medically underserved populations [1]
As of this writing, there is no published randomized, placebo-controlled trial specifically examining GLP-1 agonists as a treatment for BED
Older medications include liraglutide (Saxenda), naltrexone-bupropion (Contrave), phentermine-topiramate (Qsymia), and orlistat (Alli, Xenical)
Increased Calorie Expenditure - with the addition of MitoBurn and GBB, our formula increases thermogenesis and ramps up the amount of calories you burn throughout the day
In 2019, the FDA approved increasing the available doses of Ozempic to 2 mg